150 related articles for article (PubMed ID: 37317670)
21. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I
PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396
[TBL] [Abstract][Full Text] [Related]
22. mTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia.
Chen G; Tang L; Wei W; Li Z; Li Y; Duan X; Chen H
Sci Rep; 2016 Nov; 6():37805. PubMed ID: 27886260
[TBL] [Abstract][Full Text] [Related]
23. Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.
Wang F; Zhang J; Zhou G
Arch Oral Biol; 2019 Feb; 98():26-31. PubMed ID: 30419486
[TBL] [Abstract][Full Text] [Related]
24. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
25. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
26. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat.
Lu Q; Gao L; Huang L; Ruan L; Yang J; Huang W; Li Z; Zhang Y; Jin K; Zhuge Q
J Neuroinflammation; 2014 Mar; 11():44. PubMed ID: 24602288
[TBL] [Abstract][Full Text] [Related]
28. CD4
Liu S; Tao Z; Lou J; Li R; Fu X; Xu J; Wang T; Zhang L; Shang W; Mao Y; Wang F
J Transl Med; 2023 Nov; 21(1):803. PubMed ID: 37950246
[TBL] [Abstract][Full Text] [Related]
29. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
30. Alterations of hypoxia-induced factor signaling pathway due to mammalian target of rapamycin (mTOR) suppression in ovarian clear cell adenocarcinoma: in vivo and in vitro explorations for clinical trial.
Hirasawa T; Miyazawa M; Yasuda M; Shida M; Ikeda M; Kajiwara H; Matsui N; Fujita M; Muramatsu T; Mikami M
Int J Gynecol Cancer; 2013 Sep; 23(7):1210-8. PubMed ID: 23899586
[TBL] [Abstract][Full Text] [Related]
31. Activation of Gonadotropin-releasing Hormone Receptor Impedes the Immunosuppressive Activity of Decidual Regulatory T Cells via Deactivating the Mechanistic Target of Rapamycin Signaling.
Wang X; Zhong L; Liu Q; Cai P; Zhang P; Lu Z; Li X; Liu J
Immunol Invest; 2022 Jul; 51(5):1330-1346. PubMed ID: 34132158
[TBL] [Abstract][Full Text] [Related]
32. TIGIT enhances CD4
Chen F; Xu Y; Chen Y; Shan S
Cancer Med; 2020 May; 9(10):3584-3591. PubMed ID: 32212317
[TBL] [Abstract][Full Text] [Related]
33. Circulating CD4
Li R; Xu J; Wu M; Liu S; Fu X; Shang W; Wang T; Jia X; Wang F
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837407
[No Abstract] [Full Text] [Related]
34. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C
Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606
[TBL] [Abstract][Full Text] [Related]
35. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
36. Oxidative Stress Promotes Instability of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Shimojima Y; Kishida D; Ichikawa T; Takamatsu R; Nomura S; Sekijima Y
Front Immunol; 2021; 12():789740. PubMed ID: 34950150
[TBL] [Abstract][Full Text] [Related]
37. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients.
Li F; Ji L; Wang W; Hua F; Zhan Y; Zou S; Yuan L; Ke Y; Min Z; Song D; Sun L; Chen H; Cheng Y
Immunol Res; 2015 Mar; 61(3):269-80. PubMed ID: 25550089
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.
Huijts CM; Santegoets SJ; Quiles Del Rey M; de Haas RR; Verheul HM; de Gruijl TD; van der Vliet HJ
Clin Immunol; 2016 Jul; 168():47-54. PubMed ID: 27189717
[TBL] [Abstract][Full Text] [Related]
39. Mammalian target of rapamycin controls glucose consumption and redox balance in human Sertoli cells.
Jesus TT; Oliveira PF; Silva J; Barros A; Ferreira R; Sousa M; Cheng CY; Silva BM; Alves MG
Fertil Steril; 2016 Mar; 105(3):825-833.e3. PubMed ID: 26698679
[TBL] [Abstract][Full Text] [Related]
40. The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus.
Wang F; Zhang J; Zhou G
Immunobiology; 2020 May; 225(3):151933. PubMed ID: 32201095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
